Literature DB >> 20471503

SIRT1 and p53, effect on cancer, senescence and beyond.

Jingjie Yi1, Jianyuan Luo.   

Abstract

NAD(+)-dependent Class III histone deacetylase SIRT1 is a multiple function protein critically involved in stress responses, cellular metabolism and aging through deacetylating a variety of substrates including p53, forkhead-box transcription factors, PGC-1alpha, NF-kappaB, Ku70 and histones. The first discovered non-histone target of SIRT1, p53, is suggested to play a central role in SIRT1-mediated functions in tumorigenesis and senescence. SIRT1 was originally considered to be a potential tumor promoter since it negatively regulates the tumor suppressor p53 and other tumor suppressors. There is new evidence that SIRT1 acts as a tumor suppressor based on its role in negatively regulating beta-catenin and survivin. This review provides an overview of current knowledge of SIRT1-p53 signaling and controversies regarding the functions of SIRT1 in tumorigenesis. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471503      PMCID: PMC2989880          DOI: 10.1016/j.bbapap.2010.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  68 in total

Review 1.  The transcriptional role of PML and the nuclear body.

Authors:  S Zhong; P Salomoni; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

Review 2.  HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.

Authors:  Capucine Fleuriel; Majid Touka; Gaylor Boulay; Cateline Guérardel; Brian R Rood; Dominique Leprince
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

3.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

Review 4.  Sirtuin activators.

Authors:  Francisco J Alcaín; José M Villalba
Journal:  Expert Opin Ther Pat       Date:  2009-04       Impact factor: 6.674

Review 5.  Sirtuin inhibitors.

Authors:  Francisco J Alcaín; José M Villalba
Journal:  Expert Opin Ther Pat       Date:  2009-03       Impact factor: 6.674

6.  Inhibition of SUV39H1 methyltransferase activity by DBC1.

Authors:  Zhenyu Li; Lihong Chen; Neha Kabra; Chuangui Wang; Jia Fang; Jiandong Chen
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

Review 7.  Caloric restriction, SIRT1 and longevity.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Trends Endocrinol Metab       Date:  2009-08-25       Impact factor: 12.015

Review 8.  How does SIRT1 affect metabolism, senescence and cancer?

Authors:  Christopher L Brooks; Wei Gu
Journal:  Nat Rev Cancer       Date:  2008-12-29       Impact factor: 60.716

9.  Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.

Authors:  E Lara; A Mai; V Calvanese; L Altucci; P Lopez-Nieva; M L Martinez-Chantar; M Varela-Rey; D Rotili; A Nebbioso; S Ropero; G Montoya; J Oyarzabal; S Velasco; M Serrano; M Witt; A Villar-Garea; A Imhof; A Inhof; J M Mato; M Esteller; M F Fraga
Journal:  Oncogene       Date:  2008-12-08       Impact factor: 9.867

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more
  103 in total

1.  Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

Authors:  Anusara Daenthanasanmak; Supinya Iamsawat; Paramita Chakraborty; Hung D Nguyen; David Bastian; Chen Liu; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  Blood       Date:  2018-12-04       Impact factor: 22.113

2.  The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation.

Authors:  Jingling Jin; Polina Iakova; Yanjun Jiang; Estela E Medrano; Nikolai A Timchenko
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

Review 3.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

4.  Stress Inducibility of SIRT1 and Its Role in Cytoprotection and Cancer.

Authors:  Rachel Raynes; Jessica Brunquell; Sandy D Westerheide
Journal:  Genes Cancer       Date:  2013-03

5.  The diversity of histone versus nonhistone sirtuin substrates.

Authors:  Paloma Martínez-Redondo; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2013-03

6.  Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.

Authors:  Taro Amagata; Jing Xiao; Yi-Pei Chen; Nicholas Holsopple; Allen G Oliver; Trevor Gokey; Anton B Guliaev; Katsuhiko Minoura
Journal:  J Nat Prod       Date:  2012-11-20       Impact factor: 4.050

Review 7.  Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition.

Authors:  Ya-Huei Kuo; Jing Qi; Guerry J Cook
Journal:  Exp Hematol       Date:  2016-02-26       Impact factor: 3.084

8.  Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1.

Authors:  Shaobin Wang; Ping Song; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 9.  SIRT1 regulation modulates stroke outcome.

Authors:  Valérie Petegnief; Anna M Planas
Journal:  Transl Stroke Res       Date:  2013-08-15       Impact factor: 6.829

10.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.